Would an eye-risk warning make you think twice about Ozempic or Zepbound?
by doseCheckOdds698 votes
The FDA is making GLP-1 drugs like Ozempic, Wegovy, Mounjaro and Zepbound add a warning about a possible higher risk of a rare, serious eye condition. Millions of people take them for weight loss or diabetes. Would that label change your mind?
Vote and see results · No sign-up required